RS Therapeutics Inc.
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- January 17, 2022 – March 1, 2023
- Reference
- nrc-cnrc:172-2021-2022-Q4-984528
Published purpose
The project will develop a medicated topical foam for the treatment of inflammatory diseases like rheumatoid arthritis, osteoarthritis, joint and/or back pain due to injuries. A localized treatment of inflammation will lower the systemic exposure of the drug and this will decrease possible side effects.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions